APA

Straus D. J., Portlock C. S., Qin J., Myers J., Zelenetz A. D., Moskowitz C., Noy A., Goy A. & Yahalom J. (20041230). Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. : Blood.

Chicago

Straus David J, Portlock Carol S, Qin Jing, Myers Jane, Zelenetz Andrew D, Moskowitz Craig, Noy Ariela, Goy André and Yahalom Joachim. 20041230. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. : Blood.

Harvard

Straus D. J., Portlock C. S., Qin J., Myers J., Zelenetz A. D., Moskowitz C., Noy A., Goy A. and Yahalom J. (20041230). Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. : Blood.

MLA

Straus David J, Portlock Carol S, Qin Jing, Myers Jane, Zelenetz Andrew D, Moskowitz Craig, Noy Ariela, Goy André and Yahalom Joachim. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. : Blood. 20041230.